Chris Vercammen

4.5k total citations
24 papers, 823 citations indexed

About

Chris Vercammen is a scholar working on Surgery, Obstetrics and Gynecology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chris Vercammen has authored 24 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 11 papers in Obstetrics and Gynecology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chris Vercammen's work include Gestational Diabetes Research and Management (11 papers), Diabetes Management and Research (10 papers) and Bariatric Surgery and Outcomes (9 papers). Chris Vercammen is often cited by papers focused on Gestational Diabetes Research and Management (11 papers), Diabetes Management and Research (10 papers) and Bariatric Surgery and Outcomes (9 papers). Chris Vercammen collaborates with scholars based in Belgium, Japan and Canada. Chris Vercammen's co-authors include Christophe De Block, Chantal Mathieu, Jan Ceuppens, Bart Keymeulen, Sara Charleer, Pieter Gillard, Frank Nobels, Toon Maes, Steffen Fieuws and Régis Radermecker and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Chris Vercammen

24 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Vercammen Belgium	15	441	418	297	266	110	24	823
Magnus Ekelund Sweden	14	375 0.9×	297 0.7×	243 0.8×	184 0.7×	101 0.9×	30	675
Lois Jovanovič United States	14	462 1.0×	296 0.7×	294 1.0×	189 0.7×	130 1.2×	26	833
Georgia Kassi Greece	11	248 0.6×	165 0.4×	37 0.1×	130 0.5×	38 0.3×	27	436
Tamar Eshkoli Israel	11	125 0.3×	108 0.3×	309 1.0×	87 0.3×	328 3.0×	36	624
Randi K. Johnson United States	12	204 0.5×	180 0.4×	24 0.1×	251 0.9×	55 0.5×	32	536
P.G. Whittaker United Kingdom	8	155 0.4×	57 0.1×	89 0.3×	54 0.2×	95 0.9×	13	464
B. García Cuartero Spain	8	190 0.4×	150 0.4×	12 0.0×	173 0.7×	51 0.5×	21	394
É Baranyi Hungary	8	42 0.1×	64 0.2×	207 0.7×	59 0.2×	91 0.8×	16	406
R. H. Greenwood United Kingdom	6	170 0.4×	87 0.2×	61 0.2×	66 0.2×	20 0.2×	9	343
C. Marin Deugarte United States	8	150 0.3×	38 0.1×	85 0.3×	91 0.3×	202 1.8×	13	843

Countries citing papers authored by Chris Vercammen

Since Specialization

Citations

This map shows the geographic impact of Chris Vercammen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Vercammen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Vercammen more than expected).

Fields of papers citing papers by Chris Vercammen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Vercammen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Vercammen. The network helps show where Chris Vercammen may publish in the future.

Co-authorship network of co-authors of Chris Vercammen

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Vercammen. A scholar is included among the top collaborators of Chris Vercammen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Vercammen. Chris Vercammen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keymeulen, Bart, Christophe De Block, Liesbeth Van Huffel, et al.. (2025). One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort study. Diabetologia. 68(5). 948–960. 6 indexed citations

Hoorenbeeck, Kim Van, Toon Maes, Chris Vercammen, et al.. (2023). The Belgian Diabetes in Pregnancy Follow-Up Study (BEDIP-FUS): A Multi-Centric Prospective Cohort Study on the Long-Term Metabolic Risk across Different Degrees of Gestational Glucose Intolerance: Methodology and Design. Journal of Clinical Medicine. 12(3). 1025–1025. 1 indexed citations

Charleer, Sara, Steffen Fieuws, Christophe De Block, et al.. (2023). Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial. The Lancet Diabetes & Endocrinology. 11(2). 96–108. 27 indexed citations

Charleer, Sara, Steffen Fieuws, Christophe De Block, et al.. (2022). The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial. Journal of Diabetes Science and Technology. 18(3). 660–666. 5 indexed citations

Charleer, Sara, Steffen Fieuws, Christophe De Block, et al.. (2021). Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. The Lancet. 397(10291). 2275–2283. 107 indexed citations

Charleer, Sara, Eveline Dirinck, Kristien J. Ledeganck, et al.. (2021). Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 107(2). e570–e581. 80 indexed citations

Gillard, Pieter, Sara Charleer, Kristien J. Ledeganck, et al.. (2020). Quality of life versus glycaemic variability and time in range in people with type 1 diabetes : sub study of the RESCUE-trial. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

Benhalima, Katrien, Paul Van Crombrugge, Carolien Moyson, et al.. (2020). Women with Mild Fasting Hyperglycemia in Early Pregnancy Have More Neonatal Intensive Care Admissions. The Journal of Clinical Endocrinology & Metabolism. 106(2). e836–e854. 15 indexed citations

Charleer, Sara, Christophe De Block, Frank Nobels, et al.. (2020). Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study. Diabetes Care. 43(12). 3016–3023. 30 indexed citations

10.

Benhalima, Katrien, Paul Van Crombrugge, Carolien Moyson, et al.. (2020). Estimating the risk of gestational diabetes mellitus based on the 2013 WHO criteria: a prediction model based on clinical and biochemical variables in early pregnancy. Acta Diabetologica. 57(6). 661–671. 34 indexed citations

11.

Benhalima, Katrien, Paul Van Crombrugge, Carolien Moyson, et al.. (2020). Predictors of neonatal adiposity and associations by fetal sex in women with gestational diabetes mellitus and normal glucose-tolerant women. Acta Diabetologica. 58(3). 341–354. 7 indexed citations

12.

Hoof, L. Van, et al.. (2020). Screening and follow-up of pregestational diabetes and gestational diabetes mellitus: A survey of primary care physicians in Belgium. Primary care diabetes. 14(6). 628–632. 4 indexed citations

13.

Benhalima, Katrien, Paul Van Crombrugge, Carolien Moyson, et al.. (2019). Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance. Diabetologia. 62(11). 2118–2128. 105 indexed citations

14.

Benhalima, Katrien, Paul Van Crombrugge, Carolien Moyson, et al.. (2019). Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria. European Journal of Endocrinology. 180(6). 353–363. 42 indexed citations

15.

Benhalima, Katrien, Paul Van Crombrugge, Carolien Moyson, et al.. (2019). Prediction of Glucose Intolerance in Early Postpartum in Women with Gestational Diabetes Mellitus Based on the 2013 WHO Criteria. Journal of Clinical Medicine. 8(3). 383–383. 22 indexed citations

16.

Benhalima, Katrien, Paul Van Crombrugge, Carolien Moyson, et al.. (2018). A Modified Two-Step Screening Strategy for Gestational Diabetes Mellitus Based on the 2013 WHO Criteria by Combining the Glucose Challenge Test and Clinical Risk Factors. Journal of Clinical Medicine. 7(10). 351–351. 22 indexed citations

17.

Charleer, Sara, Chantal Mathieu, Frank Nobels, et al.. (2018). Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study. The Journal of Clinical Endocrinology & Metabolism. 103(3). 1224–1232. 143 indexed citations

18.

Benhalima, Katrien, Paul Van Crombrugge, Johan Verhaeghe, et al.. (2014). The Belgian Diabetes in Pregnancy Study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design. BMC Pregnancy and Childbirth. 14(1). 226–226. 25 indexed citations

19.

Muls, Erik, et al.. (1995). Sequential Management of Hypercholesterolaemia with a Fibrate and Simvastatin. Clinical Drug Investigation. 9(2). 116–126. 3 indexed citations

20.

Stals, H, et al.. (1994). Acanthosis nigricans Caused by Nicotinic Acid: Case Report and Review of the Literature. Dermatology. 189(2). 203–206. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact